Akers Biosciences (AKR)

Company name:Akers Bio
EPIC:AKRTrading Currency:GBX
Market Sector:AIMISIN:US00973E1029
Market Segment:AIMShare Type:DE
WWW Address:http://www.akersbiosciences.com/Description:COM SHS NPV
Industry Sector:HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Ask Open High Low Volume
 80.00 .advfn.com/imagesnew/2/us/dot 0.0 [0.00] 70.00 90.00 80.00 80.00 80.00 -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 7.10 8.87 0.02 -47.41 - - - 245.00 - 80.00

Akers Biosciences Key Figures

(at previous day's close)
Market Cap.7.10m
Shares In Issue8.87m
Prev. Close80.00
PE Ratio- 
Dividend Yield-%
EPS - basic-47.41p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-38.08p
Return On Equity (ROE)-97.33%
Operating Margin-111.57%
PEG Factor- 
EPS Growth Rate-%
Dividends PS Growth Rate-%
Net Debt1.32m
Gross Gearing33.38%
Quick Assets1.15m
Net Working Capital1.43m
Intangibles / Fixed Assets79.96%
Turnover PS27.02p
Pre-Tax Profit PS-30.15p
Retained Profit PS-30.09p
Cash PS0.66p
Net Cash PS-14.83p
Net Tangible Asset Value PS *19.04p
Net Asset Value PS30.92p
Spread20.00 (22.22%) 

Akers Biosciences Balance Sheet

LSE:AKR:Liabilities+EQLSE:AKR:Assets

Share Price Performance

Sample Period HighLow
1 week80.0080.00
4 weeks100.0080.00
12 weeks112.5080.00
1 year245.0080.00

Share Price Chart (5 years)

Akers Biosciences Historic Returns

Giorni da oggi OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week80.00--80.000.0080.00
4 weeks100.00-20.00-20.0080.000.0081.93
12 weeks112.50-32.50-28.8980.000.0097.49
26 weeks105.00-25.00-23.8180.000.00124.70
1 year230.00-150.00-65.2280.000.00155.14
3 years235.00-155.00-65.9680.000.00209.49
5 years108.75-28.75-26.4480.0017.59317.76

Akers Biosciences Key Management Ratios

Akers Biosciences Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.06 
Tobin's Q Ratio (excl. intangibles)1.34 
Dividend Yield-%
Market-to-Book Ratio2.59 
Price-to-Pre-Tax Profit PS-2.65 
Price-to-Retained Profit PS-2.66 
Price-to-Cash Flow PS-2.10 
Price-to-Sales PS2.96 
Price-to-Net Tangible Asset Value PS4.20 
Price-to-Cash PS120.58 
Net Working Capital PS16.06 
Price Pct to Working Capital PS4.98%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Akers Biosciences Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing31.95%
Net Gearing (excl. Intangibles)42.94%
Gross Gearing33.38%
Gross Gearing (excl. Intangibles)44.87%
Gearing Under 1 Year33.38%
Gearing Under 1 Year (excl. Intgbl)44.87%
Assets/Equity1.50 
Cash/Equity2.15 
(Liquidity Ratios)
Net Working Capital to Total Assets34.60%
Current Ratio2.04 
Quick Ratio (Acid Test)0.84 
Liquidity Ratio0.04 
Cash & Equiv/Current Assets2.10%
(Solvency Ratios)
Enterprise Value7.04m
CFO/Sales-1.41 
CFO/Attributable Profit- 
CFO/Assets-0.82 
CFO/Debt-2.46 
Total Debt/Equity Market Value0.19 
Total Debt/Sales0.57 
Total Debt/Pre-Tax Profit-0.51 
Total Debt1.37m
Total Debt/Net Current Assets0.96%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-2.59%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
0.0179-0.0193

Akers Biosciences Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-97.52%
Return On Assets (ROA)-39.98%
Net Profit Margin-111.36%
Assets Turnover0.36 
Return On Equity (ROE)-97.33%
Return On Investment (ROI)-53.45%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-111.36%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.48 
Fixed Assets Turnover1.40 
Current Assets Turnover0.48 
Net Working Capital Turnover 
Inventory Turnover1.51 
(Other Operating Ratios)
Total Assets-to-Sales2.79 
Debtors-to-Sales42.42%
Debt Collection Period154.83Days

Akers Biosciences Dividends

Sorry No Data Available

Akers Biosciences Fundamentals

 31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
turnover3.58100.00%4.43100.00%2.12100.00%2.96100.00%m
pre tax profit-1.53-42.67%-3.13-70.64%-9.58-453.00%-3.30-111.57%m
attributable profit-1.53-42.67%-3.14-70.99%-9.31-440.27%-3.30-111.36%m
retained profit-1.53-42.67%-3.14-70.99%-9.31-440.27%-3.30-111.36%m
eps - basic-96.00 -66.00 -181.00 -61.00 
eps - diluted-96.00 -66.00 -181.00 -61.00 
dividends per share- - - - 

Akers Biosciences Balance Sheet

 31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
LSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:AssetsLSE:AKR:Liabilities+EQLSE:AKR:Assets
 31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
ASSETS
fixed assets fixed assets0.274.40%0.201.21%0.253.04%0.265.10%m
intangibles intangibles2.4340.07%2.1813.07%1.4717.81%1.3025.60%m
fixed investments fixed investments0.000.07%0.000.03%0.070.81%0.071.31%m
current assets - other current assets - other0.162.70%9.3756.29%4.2150.91%0.050.98%m
stocks stocks1.0316.87%0.915.44%1.1313.68%2.0440.05%m
debtors debtors2.0834.18%3.5421.23%0.748.90%1.3025.52%m
cash & securities cash & securities0.101.71%0.462.74%0.404.86%0.071.43%m
TOTAL6.08100%16.65100%8.27100%5.09100%m
LIABILITIES
creditors - short creditors - short1.9532.15%1.8411.07%1.6720.17%1.7033.38%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL1.9532.15%1.8411.07%1.6720.17%1.7033.38%m
EQUITY
ord cap, reserves ord cap, reserves4.1267.85%14.8188.93%6.6079.83%3.3966.62%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL4.1267.85%14.8188.93%6.6079.83%3.3966.62%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Akers Biosciences Cash Flow Statement

31 Dec 2013 (USD)31 Dec 2014 (USD)31 Dec 2015 (USD)31 Dec 2016 (USD)
Operating CF-2.73-3.88-5.13-4.17m
Pre-Financing CF-2.66-13.17-0.05-0.33m
Retained CF-0.530.35-0.05-0.33m

Akers Biosciences Brokers

NameActivityTypeMnemonicCode
Arbuthnot Securities LimitedMarket Maker(MMF)Broker/DealerARBTALESGB31MKT
Commerzbank AGMarket Maker(MMF)Broker/DealerKLWTDRESGB2LPST
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MMF)Broker/DealerJEFFJEFFGB2X
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V:us D:20170817 09:34:13